Cargando…

Findings from a Roundtable Discussion with US Stakeholders on Valuation of the EQ-5D-Y-3L

OBJECTIVES: The International Valuation Protocol for the valuation of the EQ-5D-Y-3L provides baseline guidance, but country-specific context is also important. This study aimed to obtain US stakeholders’ input on key considerations for youth valuation in the US. METHODS: A total of 14 stakeholders...

Descripción completa

Detalles Bibliográficos
Autores principales: Nazari, Jonathan L., Pickard, A. Simon, Gu, Ning Yan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9758239/
https://www.ncbi.nlm.nih.gov/pubmed/36443519
http://dx.doi.org/10.1007/s40273-022-01222-x
_version_ 1784851999731220480
author Nazari, Jonathan L.
Pickard, A. Simon
Gu, Ning Yan
author_facet Nazari, Jonathan L.
Pickard, A. Simon
Gu, Ning Yan
author_sort Nazari, Jonathan L.
collection PubMed
description OBJECTIVES: The International Valuation Protocol for the valuation of the EQ-5D-Y-3L provides baseline guidance, but country-specific context is also important. This study aimed to obtain US stakeholders’ input on key considerations for youth valuation in the US. METHODS: A total of 14 stakeholders representing various backgrounds were identified via the investigators’ networks. A 2-h online meeting was held to discuss (1) the need for a US value set for the EQ-5D-Y-3L; (2) willingness to pay more for quality-adjusted life-year (QALY) gains for children versus adults; (3) sampling strategies; (4) framing perspectives; and (5) other challenges. The session was recorded, transcribed, and summarized. RESULTS: Several stakeholders supported paying more for QALY gains for children in recognition of their potential future contributions to society, as well as to avoid potential undervaluation and promote access to innovative treatments. Concerns regarding possible double counting, lack of data to showcase long-term benefits, and dangers of paying more for certain subgroups were also expressed. Most of the stakeholders felt that adolescents could relate to a 10-year-old’s perspective better than adults and were capable of self-completing valuation tasks, and thus should be directly included in the valuation study. There were concerns that adults would be inconsistent in their views about a 10-year-old, partly depending on their status as a parent. CONCLUSIONS: US stakeholders provided insights relevant to youth valuation in a US context and were open to continued dialogue with investigators. This study could be useful to investigators who are conducting youth valuation studies in different countries and seeking stakeholder input.
format Online
Article
Text
id pubmed-9758239
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-97582392022-12-18 Findings from a Roundtable Discussion with US Stakeholders on Valuation of the EQ-5D-Y-3L Nazari, Jonathan L. Pickard, A. Simon Gu, Ning Yan Pharmacoeconomics Original Research Article OBJECTIVES: The International Valuation Protocol for the valuation of the EQ-5D-Y-3L provides baseline guidance, but country-specific context is also important. This study aimed to obtain US stakeholders’ input on key considerations for youth valuation in the US. METHODS: A total of 14 stakeholders representing various backgrounds were identified via the investigators’ networks. A 2-h online meeting was held to discuss (1) the need for a US value set for the EQ-5D-Y-3L; (2) willingness to pay more for quality-adjusted life-year (QALY) gains for children versus adults; (3) sampling strategies; (4) framing perspectives; and (5) other challenges. The session was recorded, transcribed, and summarized. RESULTS: Several stakeholders supported paying more for QALY gains for children in recognition of their potential future contributions to society, as well as to avoid potential undervaluation and promote access to innovative treatments. Concerns regarding possible double counting, lack of data to showcase long-term benefits, and dangers of paying more for certain subgroups were also expressed. Most of the stakeholders felt that adolescents could relate to a 10-year-old’s perspective better than adults and were capable of self-completing valuation tasks, and thus should be directly included in the valuation study. There were concerns that adults would be inconsistent in their views about a 10-year-old, partly depending on their status as a parent. CONCLUSIONS: US stakeholders provided insights relevant to youth valuation in a US context and were open to continued dialogue with investigators. This study could be useful to investigators who are conducting youth valuation studies in different countries and seeking stakeholder input. Springer International Publishing 2022-11-29 2022 /pmc/articles/PMC9758239/ /pubmed/36443519 http://dx.doi.org/10.1007/s40273-022-01222-x Text en © The Author(s) 2022 https://creativecommons.org/licenses/by-nc/4.0/Open AccessThis article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Original Research Article
Nazari, Jonathan L.
Pickard, A. Simon
Gu, Ning Yan
Findings from a Roundtable Discussion with US Stakeholders on Valuation of the EQ-5D-Y-3L
title Findings from a Roundtable Discussion with US Stakeholders on Valuation of the EQ-5D-Y-3L
title_full Findings from a Roundtable Discussion with US Stakeholders on Valuation of the EQ-5D-Y-3L
title_fullStr Findings from a Roundtable Discussion with US Stakeholders on Valuation of the EQ-5D-Y-3L
title_full_unstemmed Findings from a Roundtable Discussion with US Stakeholders on Valuation of the EQ-5D-Y-3L
title_short Findings from a Roundtable Discussion with US Stakeholders on Valuation of the EQ-5D-Y-3L
title_sort findings from a roundtable discussion with us stakeholders on valuation of the eq-5d-y-3l
topic Original Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9758239/
https://www.ncbi.nlm.nih.gov/pubmed/36443519
http://dx.doi.org/10.1007/s40273-022-01222-x
work_keys_str_mv AT nazarijonathanl findingsfromaroundtablediscussionwithusstakeholdersonvaluationoftheeq5dy3l
AT pickardasimon findingsfromaroundtablediscussionwithusstakeholdersonvaluationoftheeq5dy3l
AT guningyan findingsfromaroundtablediscussionwithusstakeholdersonvaluationoftheeq5dy3l